Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of BBNX will decline by -1.81% over the next 2 Weeks and hit $21.49 by Friday, October 2, 2026. In that time frame, BBNX's share price is expected to range between $20.17 and $22.99.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Oct 2, 2026 | 21.14 | 23.25 | 25.19 |
| Oct 1, 2026 | 21.64 | 23.70 | 25.92 |
| Sep 30, 2026 | 21.67 | 23.77 | 25.75 |
| Sep 29, 2026 | 21.40 | 23.57 | 25.55 |
| Sep 28, 2026 | 20.66 | 22.78 | 25.10 |
| Sep 25, 2026 | 20.39 | 22.56 | 24.62 |
| Sep 24, 2026 | 20.89 | 23.01 | 25.01 |
| Sep 23, 2026 | 21.06 | 23.08 | 25.05 |
| Sep 22, 2026 | 20.73 | 22.88 | 24.86 |
| Sep 21, 2026 | 19.98 | 22.09 | 24.11 |
BBNX shares rose +2.15% in Friday, September 18, 2026's trading session, rising from a previous close of $21.43 to move at $21.89. The stock demonstrated notable intraday movement (see BBNX's key stats for a full breakdown), fluctuating between $21.21 and $22.14, a +4.38% trading range. While recent weeks have seen some volatility, BBNX has managed to secure a +12.72% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 1.53M shares changing hands, 1.56M fewer than the previous session. This amounted to $33.46M in total market activity.
Will BBNX Continue Its Upward Trend?
According to analyst ratings and projections for BBNX, Beta Bionics, Inc. shares are anticipated to increase by +13.10%, potentially reaching $25.19 per share by October 2, 2026. Short-term technical indicators currently suggest a neutral sentiment for BBNX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the BBNX stock forecast, now is a good time to buy BBNX stock because its current trading price is -5.86% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on BBNX covering social and institutional perspectives.
BBNX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into BBNX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 63.00% to 67.71%) suggest the stock is in a bullish momentum phase. The 50-day RSI, at 58.81%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 54.35%, maintains a neutral outlook for the long term. Insights into BBNX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Beta Bionics Short-Term Forecasts
BBNX Forecast For Next 5 Days
Our algorithm anticipates Beta Bionics (BBNX) stock could hit $20.38 by Sep 25, 2026. This represents a -6.90% rise from today's price, following a +4.42% change over the past five days.
BBNX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Beta Bionics, Inc. (BBNX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $20.44, which would mean a -6.62% decrease from the current price of $21.89. Projections for this period range from a high of $24.40 to a low of $16.81.
BBNX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Beta Bionics's price over the next three months point to a drop. BBNX stock is expected to peak at $30.49 on Nov 11, 2026 before potentially dipping to $14.53 on Nov 25, 2026. On average, BBNX is likely to trade around $19.53 in the coming 90 days.
Beta Bionics Stock Forecast 2025
Based on our predictive models, Beta Bionics (BBNX) is expected to trade between $14.53 and $30.49 throughout 2026. This would result in an average price of $19.26, potentially offering investors a -12.01% return from current levels.
Beta Bionics, Inc. Monthly Forecast 2026–2027
September 2026
According to our latest forecast models, Beta Bionics, Inc. (BBNX) is positioned to show a strong performance in September 2026. The price is predicted to move between $18.45 and $23.70, settling at an average of $21.01. This could translate to a -4.02% loss.
October 2026
Based on current market signals, Beta Bionics, Inc. is projected to trend october 2026. We forecast a trading range from $17.52 to $28.28, with a likely average price of $20.88. Investors could expect a potential return of -4.61%.
November 2026
Our predictive algorithms indicate Beta Bionics, Inc. stock may see a shift in November 2026. The expected range spans $14.53–$30.49, with an average target of $18.37. This represents a cautious outlook and a possible loss of -16.08%.
December 2026
Analyzing established trends, Beta Bionics, Inc. looks set to move in December 2026. Projections place the stock between $14.75 and $21.26, averaging around $17.92. This suggests a -18.14% loss from current levels.
January 2027
Market indicators suggest Beta Bionics, Inc. could experience notable changes during January 2027. Prices could fluctuate within $14.84 to $23.95, with a midpoint forecast of $19.15. The stock might deliver a -12.52% loss.
February 2027
Forecasting for February 2027, models estimate that Beta Bionics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $17.37 and $24.17, averaging $20.74. This signals a cautious trajectory with potential returns around -5.25%.
March 2027
According to our latest forecast models, Beta Bionics, Inc. (BBNX) is positioned to show a strong performance in March 2027. The price is predicted to move between $16.87 and $23.00, settling at an average of $20.19. This could translate to a -7.77% loss.
April 2027
Based on current market signals, Beta Bionics, Inc. is projected to trend april 2027. We forecast a trading range from $14.02 to $22.05, with a likely average price of $17.37. Investors could expect a potential return of -20.65%.
May 2027
Our predictive algorithms indicate Beta Bionics, Inc. stock may see a shift in May 2027. The expected range spans $14.51–$21.19, with an average target of $17.56. This represents a cautious outlook and a possible loss of -19.78%.
June 2027
Analyzing established trends, Beta Bionics, Inc. looks set to move in June 2027. Projections place the stock between $14.26 and $23.75, averaging around $18.79. This suggests a -14.16% loss from current levels.
July 2027
Market indicators suggest Beta Bionics, Inc. could experience notable changes during July 2027. Prices could fluctuate within $17.42 to $23.69, with a midpoint forecast of $20.40. The stock might deliver a -6.81% loss.
August 2027
Forecasting for August 2027, models estimate that Beta Bionics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $16.55 and $22.69, averaging $19.66. This signals a cautious trajectory with potential returns around -10.19%.
September 2027
According to our latest forecast models, Beta Bionics, Inc. (BBNX) is positioned to show a strong performance in September 2027. The price is predicted to move between $14.08 and $20.48, settling at an average of $17.01. This could translate to a -22.29% loss.
BBNX's history of dividends and stock splits also plays a role in long-term investor confidence.

